RxDoctor Payments Data

Marina Kuperman Beade

MOHS-Micrographic Surgery · Fall River, MANPI 1477572816

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.9% of the total across 39 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 21.0% — the pattern of someone who eats at a lot of different presentations.

$839in general payments, 2019–2025

Across 39 payments — averaging $21.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • LEO Pharma Inc.$176
  • Johnson & Johnson$125
  • Incyte Corporation$100
  • Genentech USA, Inc.$82
  • UCB, Inc.$70
  • Amgen$48
  • plus $237 from 12 others

What the payments were for

  • Food & beverage$77993%
  • Education$607%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$839 in reported general payments places this provider in the 55th percentile of 38 mohs-micrographic surgery providers in Massachusetts.

See all mohs-micrographic surgery providers in Massachusetts

Medicare billing

Part B allowed, 2024
$621,262
Medicare patients
517
Services billed
2,373

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin984$6,233
Cephalexin208$746
Ciprofloxacin Hcl62$274
Amoxicillin34$40

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Fall River

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →